20% With Cancer on Checkpoint Inhibitors Get Thyroid Dysfunction 20% With Cancer on Checkpoint Inhibitors Get Thyroid Dysfunction
Proportion is far higher than those found in clinical trials of the cancer drugs; study finds differences by cancer type.Medscape Medical News
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Diabetes & Endocrinology News Source Type: news
More News: Allergy | Allergy & Immunology | Cancer | Cancer & Oncology | Clinical Trials | Diabetes | Endocrinology | Study | Thyroid | Thyroid Cancer